All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements | NCIT_C151980 | [The reemergence of high grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements after a period of remission.] |
| Recurrent High Grade B-Cell Lymphoma | NCIT_C160229 | [The reemergence of high grade B-cell lymphoma after a period of remission.] |
| High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements | NCIT_C125904 | [A rare B-cell non-Hodgkin lymphoma that is characterized by the abnormal rearrangement of two genes, MYC gene and either BCL2 or BCL6 genes. Patients with this type of lymphoma usually respond poorly to standard treatments and have a poor prognosis.] |
| Pelvic Rhabdomyosarcoma | NCIT_C151981 | [Rhabdomyosarcoma involving the organs and structures in the pelvis.] |
| Rhabdomyosarcoma | NCIT_C3359 | [A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.] |
| Abdominal Rhabdomyosarcoma | NCIT_C151982 | [Rhabdomyosarcoma involving the organs and structures in the abdomen.] |
| Bone Resorption Inhibition | NCIT_C40920 | [Bone Resorption Inhibition involves interference with, or restraint of, absorption and removal of the hard connective tissue that constitutes the vertebrate skeleton and consists of a matrix of collagenous fibers impregnated chiefly with calcium phosphate and calcium carbonate and release of bone salts (phosphorus and, especially, calcium) into the extracellular fluid by osteoclasts, activated by parathyroid hormone.] |
| Unresectable Rhabdomyosarcoma | NCIT_C151983 | [Rhabdomyosarcoma which is not amenable to surgical resection.] |
| Unresectable Soft Tissue Sarcoma | NCIT_C153068 | [Soft tissue sarcoma that is not amenable to surgical resection.] |
| Refractory Burkitt Leukemia | NCIT_C151977 | [Burkitt leukemia resistant to treatment.] |
| Refractory Lymphoproliferative Disorder | NCIT_C157686 | [Lymphoproliferative disorder that is resistant to treatment.] |
| Refractory Acute Leukemia | NCIT_C148431 | [Acute leukemia that does not respond to treatment.] |
| Refractory Lymphoblastic Lymphoma | NCIT_C151978 | [Lymphoblastic lymphoma that is resistant to treatment.] |
| Refractory Non-Hodgkin Lymphoma | NCIT_C8701 | [A non-Hodgkin lymphoma which does not respond to treatment.] |
| Lymphoblastic Lymphoma | NCIT_C9360 | [A lymphoma composed of immature small to medium-sized precursor lymphoid cells (lymphoblasts). It includes the B- and T-cell lymphoblastic lymphoma.] |
| Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements | NCIT_C151979 | [High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements that is resistant to treatment.] |
| Refractory High Grade B-Cell Lymphoma | NCIT_C160233 | [High grade B-cell lymphoma that is resistant to treatment.] |
| Cervical Function Alteration | NCIT_C40929 | [Cervical Function Alteration involves a change in the quality of the existing biochemical composition or functionality of the cervix.] |
| Tobacco Use, Community and State Intervention Research | NCIT_C15990 | [Research studies that test group and population-based interventions and the dissemination of group and population-based interventions to prevent and reduce tobacco use. (NCI/TRIP)] |
| Tobacco Use, Cessation Research | NCIT_C15991 | [Studies to test and implement interventions among groups of individuals that are designed to stop current use of tobacco. (NCI/TRIP)] |